Keyrus S.A (ALKEY) Fair Value & Analysis
Technology · FR · Market cap €121M
Fair value as of: Jul 11, 2026
From 15 valuation models · updated 30 days ago
Fair value updated Jul 11, 2026, revised from €2.59 to €2.60 (+0.4%) since Jun 24, 2026. Share price +5.0% over the past month.
Below-average quality, and screening another 68% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (€3.65). The favourable scenario is already priced in.
- Weak quality (40/100) and above fair value at the same time, the margin of safety is missing on both counts.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 11, 2026.
How to read this chart
60‑month range €2.80 – €12.00 · fair‑value band €2.44 – €3.65 · the €8.02 price screens above the €2.60 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 11, 2026.
Analysis
Keyrus S.A (ALKEY) currently trades at €8.02, while our model-based Fair Value estimate is €2.60, implying the stock looks roughly 67.6% overvalued today. The Quality Score stands at 40/100 (below-average quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Keyrus S.A generated revenue of €332M at a net margin of 1.0%. Revenue declined 8.5% year over year. It earns a return on equity of 5.5%. Net debt stands at €54.9M. Fundamentals as of Jul 11, 2026
Our scenario range runs from €2.44 (bear case) to €3.65 (bull case); at €8.02, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 18% below its 52-week high and 19% above its 52-week low, currently above its 200-day average. For context, the median of 10 Technology peers we cover trades at -25% fair-value upside, at -68%, ALKEY screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 15 models by family
Widest divergence: DCF Models (€6.05) versus Dividend Discount (€0.2700). Highest evidence: Residual Income (76).
Notify me when ALKEY reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 11, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 38 · Market factors (momentum, volatility) 51
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Keyrus S.A., a consultancy company, engages in the development of data and digital solutions for performance management worldwide.
Full company description
Keyrus S.A., a consultancy company, engages in the development of data and digital solutions for performance management worldwide. It provides data advisory and consulting services, such as data and AI strategies, roadmap and scoping study, architecture and technology consulting, decision intelligence, and data governance; and data and analytic solutions, including data platforms, visualization and storytelling, quality and governance, and mesh and fabric, as well as cloud data management. The company also offers artificial intelligence (AI) literacy and understanding, strategy and prioritization, testing and development, production and scale-up, modeling and evaluation, and governance services; enterprise performance management services, such as performance analytics, consolidation and regulatory reporting, and profitability and cost management as well as planning, budgeting, and forecasting; and digital and multi-experience services, including digital strategy consulting, customer data platform, marketing automation, and omnichannel commerce. It provides its offerings under the Keyrus Life Science, Absys Cyborg, Younicorns, Vision.bi, and CMG Consulting Group brands. The company was founded in 1996 and is headquartered in Levallois-Perret, France.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Keyrus S.A reported revenue of €332M in FY2025 versus €289M in FY2021, a compound +3.5%/yr. Reported net income was €3.3M in FY2025, compounding −4.6%/yr from FY2021.
of which total revenue +6.4 pp · buybacks/dilution −0.1 pp
Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).
ALKEY screens 68% overvalued. Compare with International Business Machines Corporation →
Peer Group
Information Technology Services · 475 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Information Technology Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Information Technology Services stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| International Business Machines Corporation IBM | $235.92 | $143.90 | -39% |
| Accenture plc ACNN | 2,460 MXN | 250.95 MXN | -90% |
| Infosys Limited INFY | ₹1,156 | ₹1,457 | +26% |
| HCL Technologies Limited HCLTECH | ₹1,204 | ₹1,230 | +2% |
| Wipro Limited WIPRO | ₹178.43 | ₹226.81 | +27% |
| Tech Mahindra Limited TECHM | ₹1,455 | ₹1,086 | -25% |
| Samsung SDS Co 018260 | 199,300 KRW | 196,390 KRW | -1% |
| Persistent Systems Limited PERSISTENT | ₹5,059 | ₹2,364 | -53% |
| Hyundai Autoever Corporation 307950 | 393,000 KRW | 133,088 KRW | -66% |
| Coforge Limited COFORGE | ₹1,541 | ₹702.84 | -54% |
Compare Keyrus S.A with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Technology stocks →
Frequently asked questions
Is Keyrus S.A (ALKEY) overvalued or undervalued?
What is the fair value of ALKEY?
What is the quality score of ALKEY?
What is the revenue of Keyrus S.A (ALKEY)?
What is the net profit margin of ALKEY?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Keyrus S.A and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.